Gu et al. (2020) used radiomics features based on MRI delayed phase images to predict GPC3 expression in hepatocellular carcinoma, and the AUCs of the final radiomics model are 0.879 and 0.871 in the training and validation cohorts, respectively. This evidence concerns the gene GPC3 and hepatocellular carcinoma.